These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9564665)

  • 1. Human issues and medical economics of endometriosis. Three- vs. six-month GnRH-agonist therapy.
    Heinrichs WL; Henzl MR
    J Reprod Med; 1998 Mar; 43(3 Suppl):299-308. PubMed ID: 9564665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Add-back therapy in the treatment of endometriosis-associated pain.
    Zupi E; Marconi D; Sbracia M; Zullo F; De Vivo B; Exacustos C; Sorrenti G
    Fertil Steril; 2004 Nov; 82(5):1303-8. PubMed ID: 15533351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
    Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
    Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
    Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An economically rational method of managing early-stage endometriosis.
    Surrey E
    Med Interface; 1997 Mar; 10(3):119-24. PubMed ID: 10172946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.
    Petta CA; Ferriani RA; Abrao MS; Hassan D; Rosa E Silva JC; Podgaec S; Bahamondes L
    Hum Reprod; 2005 Jul; 20(7):1993-8. PubMed ID: 15790607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current approaches to optimizing the treatment of endometriosis in adolescents.
    Laufer MR
    Gynecol Obstet Invest; 2008; 66 Suppl 1():19-27. PubMed ID: 18936548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of GnRH agonist therapy. Review of clinical studies and their implications.
    Agarwal SK
    J Reprod Med; 1998 Mar; 43(3 Suppl):293-8. PubMed ID: 9564664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
    Kitawaki J; Kusuki I; Yamanaka K; Suganuma I
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):212-6. PubMed ID: 21474232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary gonadotropin-releasing hormone agonist therapy for suspected endometriosis: a nonsurgical approach to the diagnosis and treatment of chronic pelvic pain.
    Barbieri RL
    Am J Manag Care; 1997 Feb; 3(2):285-90. PubMed ID: 10169263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate and delayed add-back hormonal replacement therapy during ultra long GnRH agonist treatment of chronic cyclical pelvic pain.
    Al-Azemi M; Jones G; Sirkeci F; Walters S; Houdmont M; Ledger W
    BJOG; 2009 Nov; 116(12):1646-56. PubMed ID: 19735378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue.
    Bayoglu Tekin Y; Dilbaz B; Altinbas SK; Dilbaz S
    Fertil Steril; 2011 Feb; 95(2):492-6. PubMed ID: 20883991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there any correlation between stages of endometriosis and severity of chronic pelvic pain? Possibilities of treatment.
    Szendei G; Hernádi Z; Dévényi N; Csapó Z
    Gynecol Endocrinol; 2005 Aug; 21(2):93-100. PubMed ID: 16109595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III-IV. A randomized comparative trial.
    Sesti F; Pietropolli A; Capozzolo T; Broccoli P; Pierangeli S; Bollea MR; Piccione E
    Fertil Steril; 2007 Dec; 88(6):1541-7. PubMed ID: 17434511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment of endometriosis. GnRH agonists and laparoscopic surgery.
    Hemmings R
    J Reprod Med; 1998 Mar; 43(3 Suppl):316-20. PubMed ID: 9564667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance therapy involving a tapering dose of danazol or mid/low doses of oral contraceptive after gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
    Kitawaki J; Ishihara H; Kiyomizu M; Honjo H
    Fertil Steril; 2008 Jun; 89(6):1831-5. PubMed ID: 17761178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical and economic benefits of GnRH agonist in treating endometriosis.
    Glasser M
    Am J Manag Care; 1999 May; 5(5 Suppl):S316-26. PubMed ID: 10537664
    [No Abstract]   [Full Text] [Related]  

  • 18. Does response to hormonal therapy predict presence or absence of endometriosis?
    Jenkins TR; Liu CY; White J
    J Minim Invasive Gynecol; 2008; 15(1):82-6. PubMed ID: 18262150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.
    Cedars MI; Lu JK; Meldrum DR; Judd HL
    Obstet Gynecol; 1990 Apr; 75(4):641-5. PubMed ID: 2138265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Lovelace Health Systems chronic pelvic pain protocol.
    Kephart W
    Am J Manag Care; 1999 May; 5(5 Suppl):S309-15. PubMed ID: 10537663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.